Patents Assigned to AureoGen Biosciences, Inc.
  • Patent number: 8906848
    Abstract: In general, the invention relates to methods of synthesizing AbA derivatives that are useful for treating infection and amenable to further chemical elaboration. These novel methods are scalable for industrial production and employ safer, simpler, and more efficient process conditions. Furthermore, the invention also provides novel compounds and intermediates useful for implementing the methods described herein and/or for the treatment of infection.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: December 9, 2014
    Assignee: AureoGen Biosciences, inc.
    Inventors: Peter Wuts, Ake P. Elhammer
  • Publication number: 20140024578
    Abstract: In general, the invention relates to methods of synthesizing AbA derivatives that are useful for treating infection and amenable to further chemical elaboration. These novel methods are scalable for industrial production and employ safer, simpler, and more efficient process conditions. Furthermore, the invention also provides novel compounds and intermediates useful for implementing the methods described herein and/or for the treatment of infection.
    Type: Application
    Filed: March 23, 2012
    Publication date: January 23, 2014
    Applicant: AureoGen Biosciences ,Inc.
    Inventors: Peter Wuts, Ake P. Elhammer
  • Publication number: 20100112598
    Abstract: Disclosed is a simple and reproducible method for assaying inositol phosphorylceramide synthase activity that employs a fluorescence resonance energy transfer pair for measuring enzyme activity. The invention also includes a novel method for identifying IPC synthase inhibitors.
    Type: Application
    Filed: December 18, 2009
    Publication date: May 6, 2010
    Applicant: AureoGen Biosciences, Inc.
    Inventor: Ake Elhammer
  • Patent number: 7659088
    Abstract: Disclosed is a simple and reproducible method for assaying inositol phosphorylceramide synthase activity that employs a fluorescence resonance energy transfer pair for measuring enzyme activity. The invention also includes a novel method for identifying IPC synthase inhibitors.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: February 9, 2010
    Assignee: AureoGen Biosciences, Inc.
    Inventor: Ake Elhammer